Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 3988

The last few years have exceeded all expectations in terms of investment activity in longevity, but much more is needed to push the field forward. With more than 40 investments in the longevity field over the past three years, LongevityTech.fund is one of the world’s most active longevity investment funds. The fund’s wide-ranging investment portfolio includes companies like BrainKey, Gerostate Alpha and Occuity.

LongevityTech.fund is now accepting new investors for its second fund, with a target fund size of $50 million up to a maximum of $100 million USD.

Longevity. Technology: LongevityTech.fund has built an impressive company portfolio that has seen no failures to date, with one IPO (longevity biotech Genflow Biosciences) and one company (longevity risk management firm Vesttoo) recently becoming the fund’s first unicorn (valued at more than $1 billion). To learn more about his views on the longevity market, we spoke to serial entrepreneur and investor Petr Sramek, LongevityTech.fund’s co-founder and managing partner.

Read more | >

Healthy mutant gene in super-fit people can reverse the decline of heart performance in the elderly, according to a study.

Injecting the genes of so-called “super-agers” into failing heart cells regenerates them, making them function as if they were 10 years younger, scientists have found.

The discovery opens the door for heart failure to be treated or prevented by reprogramming damaged cells.

Read more | >

After years of delay under government pressure, Apple said Wednesday that it will offer fully encrypted backups of photos, chat histories and most other sensitive user data in its cloud storage system worldwide, putting them out of reach of most hackers, spies and law enforcement.

Maybe a New iPhone is a good idea for a second phone.

The one service Apple offered that could not be encrypted was iCloud. Now that will change.

Read more | >

Health care integration has long been touted as a panacea for reining in health care costs and boosting quality of care.

But integrated health systems appear to be failing on both fronts, according to the results of a new nationwide study led by researchers at Harvard and the National Bureau of Economic Research (NBER).

Instead, the analysis finds marginally better care at significantly higher costs for patients seen in health systems, compared to those at independent practices or hospitals.

Read more | >

Cancer cells can shrink or super-size themselves to survive drug treatment or other challenges within their environment, researchers have discovered.

Scientists at The Institute of Cancer Research, London, combined biochemical profiling technologies with to reveal how lead to differences in the size of cancer cells—and how these changes could be exploited by new treatments.

The researchers believe smaller cells could be more vulnerable to DNA-damaging agents like chemotherapy combined with targeted drugs, while larger cancer cells might respond better to immunotherapy.

Read more | >

The hypertension drug rilmenidine has been shown to slow down aging in worms, an effect that in humans could hypothetically help us live longer and keep us healthier in our latter years.

Rilmenidine was picked for this latest study because past research has shown it mimics the effects of caloric restriction on a cellular level. Reducing available energy while maintaining nutrition within the body has been shown to extend lifespans in several animal models.

Whether this translates to human biology, or is a potential risk to our health, is a topic of ongoing debate. Finding ways to achieve the same benefits without the costs of extreme calorie cutting could lead to new ways to improve health in old age.

Read more | >

In general, we tend to operate on a default assumption that other people are basically truthful and trustworthy. The growth in fake profiles and other artificial online content raises the question of how much their presence and our knowledge about them can alter this “truth default” state, eventually eroding social trust.

Changing Our Defaults

The transition to a world where what’s real is indistinguishable from what’s not could also shift the cultural landscape from being primarily truthful to being primarily artificial and deceptive.

Read more | >

Amazon employees are quickly discovering ChatGPT’s vast potential as a work assistant.

ChatGPT, the eerily intelligent chatbot that blew up since its November release, has been used in a number of different job functions at Amazon, according to internal Slack messages obtained by Insider. That includes answering job interview questions, writing software code, and creating training documents, as Insider previously reported.

One employee said in the Slack channel that the Amazon Web Services cloud unit has created a small working group to better understand AI’s impact on its business. Through testing, this team found ChatGPT does a “very good job” at answering AWS customer support questions, as most answers are based on public information. The AI tool was also “great” at creating training documents and “very strong” in corporate strategy questions.

Read more | >